Value-Added Products from Microalgae - Biotechnological Applications of Microalgae - page 158

Martek Corporation Site (2012). History of Martek—Visionary Plant Based Nutrition
Research. Online. Available at <http://www.martek.com/About/History.aspx>
(Accessed 13 February 2012).
Metting, Jr., F.B. (1996). Biodiversity and application of microalgae. Journal of Industrial
Microbiology, 17: 477-489.
Milledge, J.J. (2011). Commercial application of microalgae other than as biofuels: A brief
review. Reviews in Environmental Science and Biotechnology, 10: 31-41.
Mischoulon, D., Best-Popescu, C., Laposata, M., Merens, W., Murakami, J.L., Wu, S.L.,
Papakostas, G.I., Dording, C.M., Sonawalla, S.B., Nierenberg, A.A., Alpert, J.E.,
and Fava, M. (2008). A double-blind dose-finding pilot study of docosahexaenoic
acid (DHA) for major depressive disorder. European Neuropsychopharmacology, 18:
639-645.
Molina-Grima, E., Berlabi, E.-H., Fernandez, F.G.A., Medina, A.R., and Chisti, Y. (2003).
Recovery of microalgal biomass and metabolites: Process options and economics,
Biotechnology Advances , 20: 491-515.
Muller-Feuga, A. (2000). The role of microalgae in aquaculture: Situation and trends. Journal
of Applied Phycology, 12: 527-534.
Murthy, K.N.C., Rajesha, J., Mahadeva, S., and Ravishankar, G.A. (2005). Comparative evalu-
ation of hepatoprotective activity of carotenoids in microalgae. Journal of Medicinal
Food, 8: 523-528.
Nemets, B., Stahl, Z., and Belmaker, R.H. (2002). Addition of omega-3 fatty acids to main-
tenance medication treatment for recurrent unipolar depressive disorder. American
Journal of Psychiatry, 159: 477-479.
Ocean Nutrition Canada (2011). Market Opportunities. Online. Available at <http://www.
ocean-nutrition.com/omega3/market_opportunities> (Accessed 8 July 2011).
Olaizola, M. (2003). Commercial development of microalgal biotechnology: From the test
tube to the marketplace. Biomolecular Engineering, 20: 459-466.
Olguín, E.J. (2003). Phycoremediation: Key issues for cost-effective nutrient removal pro-
cesses. Biotechnology Advances, 22: 81-91.
Orosa, M., Torres, E., Fidalgo, P., and Abalde, J. (2000). Production and analysis of secondary
carotenoids in green algae. Journal of Applied Phycology, 12: 553-556.
Pulz, O., and Gross, W. (2004). Valuable products from biotechnology of microalgae. Applied
Microbiology and Biotechnology, 65: 635-648.
Radmer, R.J. (1996). Algal diversity and commercial algal products. Marine Biotechnology ,
46: 263-270.
Ratledge, C. (2004). Fatty acid biosynthesis in microorganisms being used for single cell oil
production. Biochimie, 86: 807-815.
Ruxton, C.H.S., Reed, S.C.S., and Millington, K.J. (2004). The health benefits of omega-3
fatty acids: A review of the evidence. Journal of Human Nutrition and Diet, 17:
449-459.
Schmidt-Dannert, C., Umeno, D., and Arnol, F.H. (2000). Molecular breeding of carotenoid
biosynthetic pathways. Nature Biotechnology, 18: 750-753.
Sekar, S., and Chandramohan, M. (2008). Phycobiliproteins as a commodity: Trends in applied
research, patents and commercialization. Journal of Applied Phycology, 20: 113-136.
Simopoulos, A.P. (1999). Essential fatty acids in health and chronic disease. The American
Journal of Clinical Nutrition, 70 (Suppl.): 560S-569S.
Singh, S., Bhushan, K.N., and Banerjee, U.C. (2005). Bioactive compounds from cyanobacte-
ria and microalgae: An overview. Critical Review Biotechnology, 25: 73-95.
Solazyme (2012). Market Areas/Overview. Online. Available at <http://solazyme.com/market-
areas> (Accessed 21 February 2012).
Sonne, P. (2010). To wash hands off palm oil Unilever embraces algae. Dow Jones and
Company website. The Wall Street Journal. Online. Available at <http://online.wsj.